Thursday, August, 22, 2019 01:09:49
Page125.org
Menu
  • Medical Devices
  • Biotechnology
  • Healthcare IT
  • Pharmaceuticals
Trending News:
  • Fulcrum bags global rights for GSK’s failed trial drug Losmapimod
  • Lilly & Avidity ink new licensing & research collaboration agreement
  • Alembic Pharma receives FDA approval for Teriflunomide tablets
  • Roche Pharma introduces Hemophilia A treatment drug in India
Home
Contact US

Contact US

Physical Address

We are moving...
We will update our new address soon.
e-Mail: [email protected]

Contact for News

Ojaswita Kutepatil[email protected] https://twitter.com/ojaswita_k
Shikha Sinha[email protected] https://twitter.com/shikhas999/
Editor[email protected]

Latest News

Fulcrum bags global rights for GSK’s failed trial drug Losmapimod

Fulcrum bags global rights for GSK’s failed trial drug Losmapimod

Lilly & Avidity ink new licensing & research collaboration agreement

Lilly & Avidity ink new licensing & research collaboration agreement

Alembic Pharma receives FDA approval for Teriflunomide tablets

Alembic Pharma receives FDA approval for Teriflunomide tablets

Roche Pharma introduces Hemophilia A treatment drug in India

Roche Pharma introduces Hemophilia A treatment drug in India

FDA prohibits Coloplast, Boston Scientific from selling surgical mesh

FDA prohibits Coloplast, Boston Scientific from selling surgical mesh

MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS

MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS

  • About Us
  • Privacy Policy
  • Editorial Policy
  • Our Team
  • Contact US

Physical Address

We are moving...
We will update our new address soon.
e-Mail: [email protected]
Page125.org Copyright © 2019.